“

[ Drug companies ] really utilize the scientific literature, and most of the literature is coming out of big academic labs, if academic labs are shut down for months and research continuities are disrupted, it's going to take several more months to gain momentum again and people won't be producing results for some time... That could really put a lag on the drug discovery pipeline that we have going with industry.